Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study
Gawryś, K.; Turek-Jakubowska, A.; Gawryś, J.; Jakubowski, M.; Dębski, J.; Szahidewicz-Krupska, E.; Trocha, M.; Derkacz, A.; Doroszko, A. Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study. J. Clin. Med. 2022, 11, 1198. https://doi.org/10.3390/jcm11051198
Gawryś K, Turek-Jakubowska A, Gawryś J, Jakubowski M, Dębski J, Szahidewicz-Krupska E, Trocha M, Derkacz A, Doroszko A. Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study. Journal of Clinical Medicine. 2022; 11(5):1198. https://doi.org/10.3390/jcm11051198
Chicago/Turabian StyleGawryś, Karolina, Aleksandra Turek-Jakubowska, Jakub Gawryś, Maciej Jakubowski, Janusz Dębski, Ewa Szahidewicz-Krupska, Małgorzata Trocha, Arkadiusz Derkacz, and Adrian Doroszko. 2022. "Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study" Journal of Clinical Medicine 11, no. 5: 1198. https://doi.org/10.3390/jcm11051198